S

Sanofi

Global pharma company; vaccines and R&D

Senior Analyst Market Research

Full-TimeDeadline 10/30/26
No salary listed
Senior
Hyderabad, Telangana, India
In PersonTravel may be required based on business need.
Data & AnalyticsData Analysis

About the job

Requirements
  • At least 5 years of experience in pharmaceutical product market research.
  • In-depth knowledge of analysis techniques and different analytical approaches.
  • Demonstrated leadership and management in driving innovation and automation using advanced statistical and analytical techniques.
  • Strong quantitative, research, and data analytical skills.
  • Knowledge of statistical and programming tools such as SPSS and Q, or similar tools.
  • Knowledge of statistical approaches including conjoint, MaxDiff, linear regression, correlation, factor analysis, and cluster analysis.
  • Advanced Microsoft Excel and Microsoft PowerPoint skills.
  • Expert knowledge of Excel and proficiency in Visual Basic for Applications.
  • Experience using analytical tools such as Power BI, Qlik Sense, Tableau, Smartsheet, and Alteryx.
  • Experience developing and managing dashboards.
  • Project management ability, including prioritizing and handling multiple projects simultaneously.
  • Ability to synthesize complex information into clear and actionable insights.
  • Solid understanding of pharmaceutical development, manufacturing, supply chain, and marketing functions.
  • Ability to work effectively across stakeholder levels and diverse functions.
  • Ability to operate effectively in an international matrix environment and across time zones.
  • Strong presentation, interpersonal, communication, learning agility, problem-solving, and strategic-thinking skills.
Responsibilities
  • Execute global Immunology market research projects and manage a consistent, timely market research process across global products.
  • Finalize questionnaires, develop recruiting lists, aggregate data, interpret results, cross-reference secondary sources, and report findings.
  • Maintain effective relationships with end stakeholders and develop education and communication content as required.
  • Lead and develop SGH operations associates and ensure new technologies are leveraged.
  • Initiate contracting processes and related documents within defined timelines and collaborate with global stakeholders on project planning and timelines.
  • Translate brand and business needs into hypotheses and establish effective analytical approaches for testing them across quantitative market research projects.
  • Draft research materials, including questionnaires, discussion guides, and stimuli, to address key business objectives.
  • Manage market research programming and fielding vendors.
  • Analyze quantitative and qualitative primary market research data to address key business objectives.
  • Develop PowerPoint presentations and accurately report insights and recommendations.
  • Synthesize insights from multiple reports to highlight key brand insights and recommendations for business decisions.
  • Own methodology and instrument design for market research projects based on stakeholder guidance.
  • Present key insights and recommendations to stakeholders when appropriate.
  • Partner with market research leads, primarily in the United States, to execute market research projects with high quality and on-time delivery.
  • Drive project management across kick-off, execution, insight generation, and data visualization phases.
  • Coordinate feedback on research materials, including screeners and questionnaires, across key market stakeholders before project initiation.
  • Participate in project scoping discussions to finalize key business questions and market research needs.
  • Collaborate with research vendors and Sanofi and Regeneron market research leads to develop and share final reports and recommendations.
  • Learn and apply Sanofi compliance requirements and internal processes to initiate and execute market research projects compliantly and on time.
  • Provide context for study findings using prior market research and secondary sources.
  • Contribute to quality enhancement by ensuring high scientific standards for outputs.
  • Ensure adherence to compliance procedures and internal operational risk controls.
  • Refresh reports on weekly, monthly, quarterly, or annual cycles and perform quality-control checks for each refresh.
  • Use current tools, technologies, and methodologies to support regular and ad hoc market research activities, including insight distillation, report generation, and insight mining.
  • Work cross-functionally to gather requirements, analyze data, and generate insights and reports for the GBU.
  • Work with global teams and external vendors to deliver designated deliverables, prioritize work, and meet time-sensitive requests.
  • Present and defend intelligence, methodology, content, and conclusions to global leadership in a clear and concise format.
Desired Qualifications
  • Experience in a pharmaceutical therapy area.
  • Experience with statistical approaches such as conjoint, MaxDiff, linear regression, correlation, factor analysis, and cluster analysis.
  • Slide creation skills that bring creativity to presentations rather than relying on text- and data-heavy slides.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • Parental Leave

Company News

Associated Press
Oct 19th, 2026
Enable Injections wins first Japan approval for enFuse on-body injector via Sanofi's CirCLIQ

Enable Injections has won its first commercial product approval in Japan. The country's Ministry of Health, Labour and Welfare approved the company's enFuse On-Body Delivery System through Sanofi's CirCLIQ Injector. The device delivers a subcutaneous form of Sarclisa (isatuximab) with the push of a button, for treating multiple myeloma. It is the first anticancer treatment given through an on-body injector in Japan. The approval follows recent clearances in the US and Europe. Japan approved Sarclisa SC in June 2026, backed by the IRAKLIA phase 3 study, which showed the subcutaneous form was non-inferior to intravenous delivery. "We're proud to partner with Sanofi to bring our enFuse technology to patients in Japan," said Michael D. Hooven, chairman and chief executive officer of Enable.

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...